Rosanne Ott, portfolio manager for the four star Alger Health Sciences Fund, says health care stocks will benefit during President Obama’s first 100 days in office, especially generic drug-makers Teva and Mylan.
Rosanne Ott, portfolio manager for the four star Alger Health Sciences Fund, says health care stocks will benefit during President Obama’s first 100 days in office, especially generic drug-makers Teva and Mylan.
Discussion
View Comments for “Obama Will Boost Biotech Industry”